TP53 and B-cell chronic lymphocytic leukemia: A number of recurrent clonal and subclonal genetic mutations of potential leukemogenic relevance (e.g., TP53, Notch, SF3B1, XPO1) have been identified, however, these mutations do not entirely explain the molecular pathogenesis of CLL or transformation to RT.